 TEL AVIV, Israel, May 20, 2021 GLOBE NEWSWIRE -- VBL Therapeutics Nasdaq: VBLT today announced that a poster providing an update on the OVAL Phase 3 registration enabling clinical trial of VB-111 in ovarian cancer will be presented at the American Society of Clinical Oncology ASCO Annual Meeting. 